Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy:
The One Ticker Retirement Plan… How to make all the money you need – in any market – using a single stock. Click here for the name of the ticker…
>>>
pixel
Glendon E. French, III net worth and biography

Glendon French, III Biography and Net Worth

CEO of Pulmonx
Glendon E. French has served as our President, Chief Executive Officer and as a member of our board of directors since December 2014. From January 2014 to November 2014, Mr. French served as Chief Executive Officer and as a director of ApniCure, a medical device company. From October 2010 to December 2012, Mr. French served as President, Pulmonary Endoscopy for Boston Scientific Corporation, a medical device company. From December 2003 to October 2010, Mr. French served as President and Chief Executive Officer and as a director of Asthmatx, Inc., a medical device company. Mr. French serves as the Executive Chairman of the board of directors of Levita Magnetics International Corp., a medical device company. Mr. French holds a B.A. in History from Dartmouth College and an M.B.A. from the Wharton School at the University of Pennsylvania. We believe that Mr. French is qualified to serve as a member of our board of directors because of his extensive leadership experience and knowledge of the medical device industry.

What is Glendon E. French, III's net worth?

The estimated net worth of Glendon E. French, III is at least $17.13 million as of September 15th, 2022. Mr. French, III owns 1,027,944 shares of Pulmonx stock worth more than $17,125,547 as of September 30th. This net worth approximation does not reflect any other investments that Mr. French, III may own. Learn More about Glendon E. French, III's net worth.

How do I contact Glendon E. French, III?

The corporate mailing address for Mr. French, III and other Pulmonx executives is , , . Pulmonx can also be reached via phone at 650-364-0400 and via email at [email protected] Learn More on Glendon E. French, III's contact information.

Has Glendon E. French, III been buying or selling shares of Pulmonx?

Over the course of the past ninety days, Glendon E. French, III has sold $1,529,500.00 of Pulmonx stock. Most recently, Glendon E. French III sold 25,000 shares of the business's stock in a transaction on Thursday, September 15th. The shares were sold at an average price of $20.00, for a transaction totalling $500,000.00. Following the completion of the sale, the chief executive officer now directly owns 1,027,944 shares of the company's stock, valued at $20,558,880. Learn More on Glendon E. French, III's trading history.

Who are Pulmonx's active insiders?

Pulmonx's insider roster includes Daniel Florin (Director), Glendon French, III (CEO), David Lehman (General Counsel), Geoffrey Rose (Insider), and Derrick Sung (CFO). Learn More on Pulmonx's active insiders.

Are insiders buying or selling shares of Pulmonx?

In the last twelve months, insiders at the sold shares 19 times. They sold a total of 222,348 shares worth more than $6,385,302.92. The most recent insider tranaction occured on September, 15th when CEO Glendon E French III sold 25,000 shares worth more than $500,000.00. Insiders at Pulmonx own 8.5 % of the company. Learn More about insider trades at Pulmonx.

Information on this page was last updated on 9/15/2022.

Glendon E. French, III Insider Trading History at Pulmonx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2022Sell25,000$20.00$500,000.001,027,944View SEC Filing Icon  
8/18/2022Sell50,000$20.59$1,029,500.001,055,884View SEC Filing Icon  
6/1/2022Sell2,523$18.05$45,540.151,104,994View SEC Filing Icon  
3/1/2022Sell1,132$25.91$29,330.12View SEC Filing Icon  
2/17/2022Sell12,500$27.22$340,250.00View SEC Filing Icon  
1/20/2022Sell12,500$25.98$324,750.00View SEC Filing Icon  
12/16/2021Sell25,000$31.05$776,250.00View SEC Filing Icon  
12/1/2021Sell1,421$32.73$46,509.33View SEC Filing Icon  
11/18/2021Sell25,000$35.98$899,500.00View SEC Filing Icon  
10/21/2021Sell25,000$39.75$993,750.00View SEC Filing Icon  
9/20/2021Sell23,571$37.36$880,612.56View SEC Filing Icon  
9/16/2021Sell25,000$38.86$971,500.001,155,370View SEC Filing Icon  
9/1/2021Sell1,421$40.09$56,967.89View SEC Filing Icon  
8/19/2021Sell25,000$36.63$915,750.00View SEC Filing Icon  
7/15/2021Sell25,000$38.73$968,250.00View SEC Filing Icon  
6/17/2021Sell25,000$42.96$1,074,000.001,252,359View SEC Filing Icon  
5/20/2021Sell25,000$41.95$1,048,750.001,219,825View SEC Filing Icon  
4/15/2021Sell25,000$43.75$1,093,750.001,229,895View SEC Filing Icon  
See Full Table

Glendon E. French, III Buying and Selling Activity at Pulmonx

This chart shows Glendon E French III's buying and selling at Pulmonx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pulmonx Company Overview

Pulmonx logo
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Read More

Today's Range

Now: $16.66
Low: $16.60
High: $17.49

50 Day Range

MA: $19.03
Low: $15.98
High: $23.99

2 Week Range

Now: $16.66
Low: $13.79
High: $45.49

Volume

203,122 shs

Average Volume

434,527 shs

Market Capitalization

$620.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58